hemeonclinx Medical News

Oncology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Oncology

For Practicing
Oncologists

Conferences

Jobs

Newsletters

My Library

Topics in
Oncology

Alternative Therapies

Anemia/Polycythemia

BMT/SCT

Basic Science/Genetics

Bone/Cartilage

Breast

Carcinogenesis

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

GI Oncology

Gynecologic Oncology

Head and Neck

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain/Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Popular Press

Renal/Urologic

Side Effects

Soft Tissue/Sarcoma

Transfusion Medicine

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

For Practicing Oncologists

MDLinx Expert Challenge Question--September 5
The Expert Challenge, MDLinx Oncology

Noninvasive Biochemical Probe Uses Light to Detect Skin Cancers
Dorothy J. Schirf, MD, MDLinx Oncology

Today's Oncology News: Colorectal Screening Guidelines Reaffirmed
D Scott Cunningham MD, PhD, MDLinx Oncology

See all

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an IL-4/STAT6 pathway
Blood, 07/23/08

Email This Article

Save in My Library

Free Abstract

Mariotti J et al. - T cell-mediated marrow graft rejection primarily resembles a Th1-type process that can be abrogated by donor Th2 cell therapy that promotes engraftment through a novel mechanism whereby cytokine polarization is transferred to host T cells.

Sponsor

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 08/07/08

Ixabepilone: A new antimitotic for the treatment of metastatic breast cancer
Annals of Pharmacotherapy, 08/18/08

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 08/21/08

...All of Basic Science/Genetics

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor